Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Margaret M. Charpentier"'
Publikováno v:
Infectious Diseases in Clinical Practice. 28:96-98
Autor:
Lamya Hamad, Kaitlin M Landolf, Kelly M Gaertner, Margaret M Charpentier, Britny Rogala, Michelle K Nguyen
Publikováno v:
Journal of Oncology Practice. 15:81-90
Oral anticancer therapy is increasingly integrated into the care of patients with cancer. Recognition and management of drug-drug interactions (DDIs) is critical to providing efficacious and safe anticancer treatment. DDIs with QTc-prolonging agents,
Publikováno v:
British Journal of Pharmacology. 168:1989-1999
Background and Purpose For four decades, 5-fluorouracil (5-FU) has been a major anti-cancer medicine. This drug is increasingly used with other anti-cancer agents such as irinotecan. Irinotecan and many others such as PPD (pentyl carbamate of p-amino
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 32:e12-e16
Fanconi's syndrome is a serious condition characterized by type II proximal renal tubular dysfunction, with urinary loss of glucose, amino acids, phosphate, bicarbonate, and potassium. Ifosfamide-induced Fanconi's syndrome is reported in about 1.4-5%
Publikováno v:
Annals of Pharmacotherapy. 45:1138-1143
To review the evidence for strict blood pressure (BP) management in the very elderly, defined as patients aged 80 years and older.A literature search was performed using PubMed (1950 through November 2010) for the MeSH terms hypertension and elderly;
Autor:
Margaret M Charpentier
Publikováno v:
Annals of Pharmacotherapy. 39:2038-2045
OBJECTIVE To review the mechanism of action and clinical data of efaproxiral use in brain metastases of breast cancer. DATA SOURCES Articles were identified through MEDLINE (1966–June 2005) and EMBASE (1980–May 2005) searches using the key words
Publikováno v:
The Annals of pharmacotherapy. 46(9)
BACKGROUND: Approximately 10% of chemotherapy agents are administered orally, with anticipated annual growth of this practice. In the future, community pharmacy practitioners will potentially serve a larger role in the management of patients with can
Autor:
Margaret M Charpentier, Anne L. Hume
Publikováno v:
Pharmacy Today. 20:38
Fatigue is one of the most distressing and common symptoms cancer patients experience. An estimated 80% of patients receiving chemotherapy, and 65% to 100% receiving radiation, experience cancer-related fatigue (CRF). Fatigue may continue for up to 1